These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28285082)

  • 1. Response Assessment in Myeloma: Practical Manual on Consistent Reporting in an Era of Dramatic Therapeutic Advances.
    Garderet L; D'Souza A; Jacobs P; van Biezen A; Schönland S; Kroeger N; Morris C; Hari P
    Biol Blood Marrow Transplant; 2017 Jul; 23(7):1193-1202. PubMed ID: 28285082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from the Spanish Registry.
    Alegre A; Granda A; Martínez-Chamorro C; Díaz-Mediavilla J; Martínez R; García-Laraña J; Lahuerta JJ; Sureda A; Bladé J; de la Rubia J; Fernández-Rañada JM; San Miguel J; ; ;
    Haematologica; 2002 Jun; 87(6):609-14. PubMed ID: 12031917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple myeloma treatment at relapse after autologous stem cell transplantation: A practical analysis.
    Malard F; Harousseau JL; Mohty M
    Cancer Treat Rev; 2017 Jan; 52():41-47. PubMed ID: 27888768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-risk multiple myeloma: a multifaceted entity, multiple therapeutic challenges.
    Muchtar E; Magen H; Gertz MA
    Leuk Lymphoma; 2017 Jun; 58(6):1283-1296. PubMed ID: 27734720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The next generation of novel therapies for the management of relapsed multiple myeloma.
    Gonsalves WI; Milani P; Derudas D; Buadi FK
    Future Oncol; 2017 Jan; 13(1):63-75. PubMed ID: 27513456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma.
    Kumar S; Paiva B; Anderson KC; Durie B; Landgren O; Moreau P; Munshi N; Lonial S; Bladé J; Mateos MV; Dimopoulos M; Kastritis E; Boccadoro M; Orlowski R; Goldschmidt H; Spencer A; Hou J; Chng WJ; Usmani SZ; Zamagni E; Shimizu K; Jagannath S; Johnsen HE; Terpos E; Reiman A; Kyle RA; Sonneveld P; Richardson PG; McCarthy P; Ludwig H; Chen W; Cavo M; Harousseau JL; Lentzsch S; Hillengass J; Palumbo A; Orfao A; Rajkumar SV; Miguel JS; Avet-Loiseau H
    Lancet Oncol; 2016 Aug; 17(8):e328-e346. PubMed ID: 27511158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response evaluation and monitoring of multiple myeloma.
    Fernández de Larrea C; Delforge M; Davies F; Bladé J
    Expert Rev Hematol; 2014 Feb; 7(1):33-42. PubMed ID: 24483347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Necessary diagnostic requirements and therapeutic recommendations in multiple myeloma].
    Jurczyszyn A; Zaucha JM; Machaczka M; Grosicki S; Dybko J; Czepiel J; Charliński G; Janda K; Knopińska-Posłuszny W; Skotnicki AB
    Przegl Lek; 2013; 70(9):744-53. PubMed ID: 24455837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial.
    Cook G; Ashcroft AJ; Cairns DA; Williams CD; Brown JM; Cavenagh JD; Snowden JA; Parrish C; Yong K; Cavet J; Hunter H; Bird JM; Pratt G; Chown S; Heartin E; O'Connor S; Drayson MT; Hockaday A; Morris TC;
    Lancet Haematol; 2016 Jul; 3(7):e340-51. PubMed ID: 27374467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in understanding prognosis in myeloma.
    Smith D; Yong K
    Br J Haematol; 2016 Nov; 175(3):367-380. PubMed ID: 27604166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance therapy in multiple myeloma.
    Mihelic R; Kaufman JL; Lonial S
    Leukemia; 2007 Jun; 21(6):1150-7. PubMed ID: 17344913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-secretory myeloma: a clinician's guide.
    Lonial S; Kaufman JL
    Oncology (Williston Park); 2013 Sep; 27(9):924-8, 930. PubMed ID: 24282993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple myeloma: is it time for biomarker-driven therapy?
    Bhutani M; Landgren O; Usmani SZ
    Am Soc Clin Oncol Educ Book; 2015; ():e493-503. PubMed ID: 25993214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of new treatment approaches in defining treatment goals in multiple myeloma--the ultimate goal is extended survival.
    Durie BG
    Cancer Treat Rev; 2010 May; 36 Suppl 2():S18-23. PubMed ID: 20472184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal residual disease in multiple myeloma: Benefits of flow cytometry.
    Galtseva IV; Davydova YO; Kapranov NM; Julhakyan HL; Mendeleeva LP
    Int J Lab Hematol; 2018 Feb; 40(1):12-20. PubMed ID: 29058372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in biology and therapy of multiple myeloma.
    Barillé-Nion S; Barlogie B; Bataille R; Bergsagel PL; Epstein J; Fenton RG; Jacobson J; Kuehl WM; Shaughnessy J; Tricot G
    Hematology Am Soc Hematol Educ Program; 2003; ():248-78. PubMed ID: 14633785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1.
    Rajkumar SV; Harousseau JL; Durie B; Anderson KC; Dimopoulos M; Kyle R; Blade J; Richardson P; Orlowski R; Siegel D; Jagannath S; Facon T; Avet-Loiseau H; Lonial S; Palumbo A; Zonder J; Ludwig H; Vesole D; Sezer O; Munshi NC; San Miguel J;
    Blood; 2011 May; 117(18):4691-5. PubMed ID: 21292775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the autologous and allogeneic transplantation strategies for multiple myeloma.
    Nishihori T; Alsina M
    Cancer Control; 2011 Oct; 18(4):258-67. PubMed ID: 21976244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple myeloma: new staging systems for diagnosis, prognosis and response evaluation.
    Rajkumar SV; Buadi F
    Best Pract Res Clin Haematol; 2007 Dec; 20(4):665-80. PubMed ID: 18070712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.